{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:20Z","timestamp":1787237840837,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Fund","doi-asserted-by":"crossref","award":["81170005"],"award-info":[{"award-number":["81170005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Fund","doi-asserted-by":"crossref","award":["81670007"],"award-info":[{"award-number":["81670007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jped.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T16:23:58Z","timestamp":1563985438000},"page":"142-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analgesic management of uncomplicated acute sickle-cell pain crisis in pediatrics: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-9097","authenticated-orcid":false,"given":"Manou Irmina","family":"Saramba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7621-2582","authenticated-orcid":false,"given":"Sandeep","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-6041","authenticated-orcid":false,"given":"Dongchi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jped.2019.05.004_bib0005","series-title":"Sickle cell disease and hematopoietic stem cell transplantation. Sickle cell disease","first-page":"3","article-title":"Clinical manifestations of sickle cell disease across the lifespan","author":"Pecker","year":"2018"},{"key":"10.1016\/j.jped.2019.05.004_bib0010","series-title":"Genes and disease","author":"Jones","year":"2008"},{"key":"10.1016\/j.jped.2019.05.004_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1526-4637.2006.00252.x","article-title":"Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes","volume":"9","author":"Jacob","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0020","series-title":"Sickle cell disease in clinical practice","first-page":"300","author":"Howard","year":"2015"},{"key":"10.1016\/j.jped.2019.05.004_bib0025","first-page":"1","article-title":"H\u00e9moglobinoses","volume":"2015","author":"Aubry","year":"2015","journal-title":"Med Trop"},{"key":"10.1016\/j.jped.2019.05.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/791498","article-title":"Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa)","volume":"2015","author":"Adewoyin","year":"2015","journal-title":"Anemia"},{"key":"10.1016\/j.jped.2019.05.004_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jped.2019.05.004_bib0040","series-title":"Disorders of hemoglobin genetics, pathophysiology, and clinical management. The molecular, cellular, and genetic basis of hemoglobin disorders","first-page":"101","article-title":"Structure and function of hemoglobin and its dysfunction in sickle cell disease","author":"Kim-Shapiro","year":"2009"},{"key":"10.1016\/j.jped.2019.05.004_bib0045","series-title":"Hematology: basic principles and practice. Red blood cells","first-page":"536","article-title":"Pathobiology of sickle cell disease","author":"Hebbel","year":"2013"},{"key":"10.1016\/j.jped.2019.05.004_bib0050","series-title":"Sickle cell disease and hematopoietic stem cell transplantation. Sickle cell disease","first-page":"41","article-title":"Pathobiology of sickle cell disease vaso-occlusion and targeted therapies","author":"Morrone","year":"2018"},{"key":"10.1016\/j.jped.2019.05.004_bib0055","series-title":"Hematology: basic principles and practice. Red blood cells","first-page":"548","article-title":"Sickle cell disease: clinical features and management","author":"Saunthararajah","year":"2013"},{"key":"10.1016\/j.jped.2019.05.004_bib0060","series-title":"Disorders of hemoglobin genetics, pathophysiology, and clinical management. Sickle cell disease","first-page":"497","article-title":"Sickle cell pain: biology, etiology, and treatment","author":"Ballas","year":"2009"},{"key":"10.1016\/j.jped.2019.05.004_bib0065","series-title":"Evidence-based management of sickle cell disease","author":"Expert Panel Report, 2014","year":"2014"},{"key":"10.1016\/j.jped.2019.05.004_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1043454214555193","article-title":"Perception of pain among pediatric patients with sickle cell pain crisis","volume":"32","author":"Fosdal","year":"2014","journal-title":"J Pediatr Oncol Nurs"},{"key":"10.1016\/j.jped.2019.05.004_bib0075","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jped.2019.05.004_bib0080","doi-asserted-by":"crossref","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999\u20132007","volume":"38","author":"Yusuf","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cpem.2010.09.002","article-title":"Evaluation and treatment of sickle cell pain in the emergency department: paths to a better future","volume":"11","author":"Zempsky","year":"2010","journal-title":"Clin Pediatr Emerg Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajem.2017.11.015","article-title":"Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises","volume":"36","author":"Kelly","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0095","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jped.2019.05.004_bib0100","article-title":"Intranasal fentanyl for the management of acute pain in children","volume":"10","author":"Murphy","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jped.2019.05.004_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AJP.0b013e3181b511ab","article-title":"Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series","volume":"26","author":"Zempsky","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jped.2019.05.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003350.pub2","article-title":"Pain management for sickle cell disease in children and adults","volume":"2","author":"Dunlop","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jped.2019.05.004_bib0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.24116","article-title":"Updates in clinical trials for hematological diseases: 2015 clinical trials update in sickle cell anemia","volume":"90","author":"Archer","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jped.2019.05.004_bib0120","series-title":"Sickle cell disease and hematopoietic stem cell transplantation. Sickle cell disease","first-page":"65","article-title":"Current non-HSCT treatments for SCD","author":"Anderson","year":"2018"},{"key":"10.1016\/j.jped.2019.05.004_bib0125","series-title":"Sickle cell anemia: from basic science to clinical practice","first-page":"75","article-title":"Red blood cells and the vaso-occlusive process","author":"Wandersee","year":"2016"},{"key":"10.1016\/j.jped.2019.05.004_bib0130","article-title":"Magnesium for treating sickle cell disease","volume":"4","author":"Than","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jped.2019.05.004_bib0135","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10739680490278592","article-title":"The perfusion paradox and vascular instability in sickle cell disease","volume":"11","author":"Nath","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.jped.2019.05.004_bib0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jri.2006.06.004","article-title":"Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway","volume":"73","author":"Rochelson","year":"2007","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jped.2019.05.004_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbadis.2004.01.002","article-title":"Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis","volume":"1689","author":"Maier","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jped.2019.05.004_bib0155","series-title":"Disorders of hemoglobin genetics, pathophysiology, and clinical management. pathophysiology of hemoglobin and its disorders","first-page":"201","article-title":"Mechanisms and clinical complications of hemolysis in sickle cell disease and thalassemia","author":"Kato","year":"2009"},{"key":"10.1016\/j.jped.2019.05.004_bib0160","first-page":"26","article-title":"Arginine and glutamine: the future of amino acid therapy in sickle cell disease","volume":"1","author":"El-Rassi","year":"2016","journal-title":"J Sick Cell Dis Hemoglobinopathies"},{"key":"10.1016\/j.jped.2019.05.004_bib0165","doi-asserted-by":"crossref","DOI":"10.3945\/jn.115.228544","article-title":"Parenteral or enteral arginine supplementation safety and efficacy","volume":"146","author":"Rosenthal","year":"2016","journal-title":"J Nutr"},{"key":"10.1016\/j.jped.2019.05.004_bib0170","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","article-title":"The discovery of nitric oxide and its role in vascular biology","volume":"147","author":"Moncada","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jped.2019.05.004_bib0175","series-title":"Disorders of hemoglobin genetics, pathophysiology, and clinical management. Pathophysiology of hemoglobin and its disorders","first-page":"185","article-title":"The biology of vascular nitric oxide","author":"Leopold","year":"2009"},{"key":"10.1016\/j.jped.2019.05.004_bib0180","article-title":"Nitric oxide, phosphodiesterase inhibitors and soluble guanylate cyclase stimulators as candidate treatments for sickle cell disease","author":"Sharma","year":"2016","journal-title":"J Sick Cell Dis Hemoglobinopathies"},{"key":"10.1016\/j.jped.2019.05.004_bib0185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.13548","article-title":"The trials and hopes for drug development in sickle cell disease","volume":"170","author":"Ataga","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jped.2019.05.004_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0195","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/acm.2012.0567","article-title":"Influence of lime juice on the severity of sickle cell anemia","volume":"19","author":"Adegoke","year":"2013","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.jped.2019.05.004_bib0200","series-title":"Lidocaine 5% plasters (Versatis\u00ae 5%) in pediatric neuropathic pains and vasoocclusive sickle cell crisis pains. clinicaltrialsgov\/ct2\/show\/NCT001314300","author":"NCT01314300","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0205","series-title":"The use of warmed saline in vaso-occlusive episode. Clinicaltrialsgov\/ct2\/show\/ NCT02316366","author":"NCT02316366","year":"2014"},{"key":"10.1016\/j.jped.2019.05.004_bib0210","series-title":"Inhaled nitric oxide for pediatric painful sickle crisis. Clinicaltrialsgov\/ct2\/show\/ NCT00142051","author":"NCT00142051","year":"2005"},{"key":"10.1016\/j.jped.2019.05.004_bib0215","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2015-05-647107","article-title":"A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children","volume":"126","author":"Brousseau","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jped.2019.05.004_bib0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjh.12019","article-title":"High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study","volume":"159","author":"Osunkwo","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jped.2019.05.004_bib0225","series-title":"Choosing opioid management for pain and analyzing acute chest syndrome (ACS) rates equally (compare). Clinicaltrialsgov\/ct2\/show\/ NCT01380197","author":"NCT01380197","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0230","series-title":"Cochrane handbook for systematic reviews of intervention. Version 5.1.0 (updated March 2011)","article-title":"Selecting studies and collecting data","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0235","series-title":"Cochrane handbook for systematic reviews of intervention. Version 5.1.0 (updated March 2011)","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0240","series-title":"Version 3.6 for Windows","author":"GRADEpro","year":"2014"},{"key":"10.1016\/j.jped.2019.05.004_bib0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jped.2019.05.004_bib0250","series-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011)","article-title":"Analysing data and undertaking meta-analysis","author":"Deeks","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BJM"},{"key":"10.1016\/j.jped.2019.05.004_bib0260","series-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011)","article-title":"Addressing reporting biases","author":"Sterne","year":"2011"},{"key":"10.1016\/j.jped.2019.05.004_bib0265","series-title":"The Nordic Cochrane Center, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3","author":"RevMan","year":"2014"},{"key":"10.1016\/j.jped.2019.05.004_bib0270","first-page":"6","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jped.2019.05.004_bib0275","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1542\/peds.2013-2065","article-title":"Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease","volume":"132","author":"Goldman","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jped.2019.05.004_bib0280","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jped.2019.05.004_bib0285","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.289.9.1136","article-title":"Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease","volume":"289","author":"Weiner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jped.2019.05.004_bib0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1740774513475850","article-title":"Sickle Cell Disease Clinical Research Network (SCDCRN). IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies","volume":"10","author":"Dampier","year":"2013","journal-title":"Clin Trials"},{"key":"10.1016\/j.jped.2019.05.004_bib0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cct.2011.11.018","article-title":"Sickle Cell Disease Clinical Research Network (SCDCRN). Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial","volume":"33","author":"Peters-Lawrence","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jped.2019.05.004_bib0300","series-title":"Randomized control trial of arginine therapy for pediatric sickle cell disease pain [Phase 2]. clinicaltrialsgov\/ct2\/show\/ NCT02536170","author":"NCT02536170","year":"2015"},{"key":"10.1016\/j.jped.2019.05.004_bib0305","series-title":"Pain management of VOC in children and young adults with SCD [Phase 2]. clinicaltrialsgov\/ct2\/show\/ NCT01954927","author":"NCT01954927","year":"2013"},{"key":"10.1016\/j.jped.2019.05.004_bib0310","author":"NCT02573714","year":"2015"},{"key":"10.1016\/j.jped.2019.05.004_bib0315","article-title":"Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatrics sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial","volume":"7","author":"Young","year":"2017","journal-title":"BJM Open"},{"key":"10.1016\/j.jped.2019.05.004_bib0320","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpainsymman.2013.03.012","article-title":"The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease","volume":"47","author":"Tawfic","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jped.2019.05.004_bib0325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00277-013-1954-3","article-title":"Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature","volume":"93","author":"Uprety","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jped.2019.05.004_bib0330","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annemergmed.2014.09.024","article-title":"The PICHFORK (pain in children fentanyl or ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries","volume":"65","author":"Graudins","year":"2015","journal-title":"Ann Emerg Med"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755719300531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755719300531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:04:02Z","timestamp":1762185842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021755719300531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0021755719300531"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2019.05.004","relation":{},"ISSN":["0021-7557"],"issn-type":[{"value":"0021-7557","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic management of uncomplicated acute sickle-cell pain crisis in pediatrics: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}